| Period Ending | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 |
|---|
|
Total Revenue
|
115,316,000
|
91,719,000
|
70,038,000
|
65,496,000
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
115,316,000
|
91,719,000
|
70,038,000
|
65,496,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 49,863,000 | 42,001,000 | 31,822,000 | 29,251,000 | | | |
Operating Income or Loss
|
65,453,000
|
49,718,000
|
38,216,000
|
36,245,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes |
-
|
-
|
-
|
-
|
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 14,634,000 | 10,782,000 | 8,029,000 | 7,332,000 |
|
Minority Interest | (82,000) | (130,000) | (136,000) | (97,000) |
|
|
|
Net Income From Continuing Ops | 50,817,000 | 39,172,000 | 30,211,000 | 28,621,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
50,735,000
|
39,042,000
|
30,075,000
|
28,524,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.09%